妊娠期SARS-CoV-2突破性感染优先诱导IgG4应答并增强胎盘转运
研究纳入165例孕妇,按感染和接种状态分为三组,纵向检测母血、母乳及分娩时母胎配对血中RBD和NP特异性IgG。结果显示,接种者突破性感染后母血和母乳中RBD特异性IgG应答高于单独感染或接种,且RBD特异性IgG向IgG4亚类偏移,突破性感染组新生儿与母体RBD特异性IgG比值最高。
要点
- 接种者突破性感染后母血和母乳RBD特异性IgG应答高于单独感染或接种。
- 突破性感染使RBD特异性IgG应答向IgG4亚类偏移。
- 突破性感染组新生儿与母体RBD特异性IgG比值最高。
核心结论
- 妊娠期突破性感染延长已有体液免疫并促进抗体经胎盘转运至新生儿,反映既往接种而非单纯感染诱导的抗体启动效应。
- 作者认为这些结果支持妊娠期继续接种更新的SARS-CoV-2疫苗以降低疾病严重程度并为新生儿提供更大保护。
研究设计与样本
- 在俄勒冈健康与科学大学纳入165例妊娠患者,按感染和接种状态分为三组。
- 通过ELISA纵向检测母血和母乳中RBD及NP特异性IgG终点滴度和光密度值,并在分娩时检测母体、脐带和新生儿配对血。
主要发现
- 接种者突破性感染后母血浆和母乳中RBD特异性IgG应答高于单独感染或单独接种。
- 突破性感染使RBD特异性IgG应答向IgG4偏移,与重复接种报道一致。
- 突破性感染组和未接种/感染组中NP特异性IgG以IgG1和IgG3为主。
- 突破性感染组新生儿与母体RBD特异性IgG比值最高,母体与新生儿分娩时滴度强相关。
临床怎么用
- 作者认为这些结果支持妊娠期继续接种更新的SARS-CoV-2疫苗以降低疾病严重程度并为新生儿提供更大保护。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Emerging SARS-CoV-2 variants and waning humoral immunity have led to increased occurrences of breakthrough infection. Pregnant individuals and neonates are particularly vulnerable to adverse outcomes associated with COVID-19. OBJECTIVE: We aimed to evaluate the maternal anti-SARS-CoV-2 IgG response and the placental transfer of antibodies to the fetus following breakthrough infection, infection in unvaccinated participants, and vaccination in the absence of infection during pregnancy. METHODS: Pregnant patients (n = 165) were enrolled at Oregon Health & Science University and assigned to three cohorts based on infection and vaccination status. Receptor-binding domain (RBD) and nucleocapsid protein (NP) specific IgG endpoint titers (EPT) and optical density (OD) values were determined via ELISA longitudinally in maternal blood and breastmilk, and at delivery in paired maternal, umbilical cord, and newborn blood. RESULTS: Breakthrough infection in vaccinated participants induced a higher maternal RBD-specific IgG response compared to infection or vaccination alone in maternal plasma and breastmilk. As reported with repeated vaccination, breakthrough infection skewed RBD-specific IgG responses toward an IgG4 response. IgG1 and IgG3 were the dominant NP-specific subclasses for both breakthrough infection and unvaccinated/infection groups. The breakthrough infection cohort had the highest newborn-to-maternal ratio of RBD-specific IgG with a strong correlation between maternal and newborn delivery titers. CONCLUSION: Breakthrough infection during pregnancy prolongs pre-existing humoral immunity and facilitates the transplacental transfer of antibodies to the neonate, reflecting an antibody priming effect induced by prior vaccination rather than infection alone. These results warrant continued administration of updated SARS-CoV-2 vaccination during pregnancy to reduce disease severity and provide greater protection to newborns.
引用
- Wagner SB, Rincon M, Keen KE, et al. SARS-CoV-2 breakthrough infection during pregnancy preferentially elicits IgG4 response and enhanced placental-transfer. Vaccine. 2025. PMID: 40639177. doi:10.1016/j.vaccine.2025.127476
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。